You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Canakinumab

Showing 1 - 25 of 115
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cigarette Smoking-Related Carcinoma, Lung Carcinoma Trial in Columbus (procedure, biological, other)

Not yet recruiting
  • Cigarette Smoking-Related Carcinoma
  • Lung Carcinoma
  • Biospecimen Collection
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 6, 2023

Patients Treated With Ilaris® for Gouty Arthritis in France

Completed
  • Gouty Arthritis
    • Paris, France
      Novartis
    Jul 20, 2023

    Postprandial Hypoglycemia Trial in Basel, Olten (Canakinumab, Placebo (0.9% NaCl))

    Recruiting
    • Postprandial Hypoglycemia
    • Canakinumab
    • Placebo (0.9% NaCl)
    • Basel, Switzerland
    • +1 more
    Nov 23, 2022

    Pancreatic Cancer Trial in New York (Canakinumab, Tislelizumab, Nab-Paclitaxel)

    Recruiting
    • Pancreatic Cancer
    • Canakinumab
    • +3 more
    • New York, New York
    • +2 more
    Aug 2, 2023

    Lung Cancer Trial in Italy (Canakinumab, Placebo)

    Terminated
    • Lung Cancer
    • Canakinumab
    • Placebo
    • Rozzano, Milano, Italy, Italy
    • +5 more
    Feb 9, 2023

    MDS Trial in Tampa (Canakinumab Injection, Darbepoetin Alfa)

    Recruiting
    • Myelodysplastic Syndromes
    • Canakinumab Injection
    • Darbepoetin Alfa
    • Tampa, Florida
      Moffitt Cancer Center
    Nov 21, 2022

    Clonal Cytopenia of Undetermined Significance Trial in Columbus (procedure, drug, other)

    Recruiting
    • Clonal Cytopenia of Undetermined Significance
    • Biospecimen Collection
    • +6 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Dec 12, 2022

    Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

    Recruiting
    • Primary Myelofibrosis
    • +4 more
    • Canakinumab
    • New York, New York
      Ruttenberg Treatment Center
    Jul 18, 2022

    Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Recurrent Chronic Myelomonocytic Leukemia Trial in Houston

    Recruiting
    • Chronic Myelomonocytic Leukemia
    • +5 more
    • Canakinumab
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 7, 2022

    Knee Osteoarthritis Trial in Worldwide (canakinumab, LNA043, Placebo to canakinumab)

    Recruiting
    • Knee Osteoarthritis
    • canakinumab
    • +2 more
    • Clearwater, Florida
    • +19 more
    Dec 14, 2022

    Carcinoma, Renal Cell Trial in New York (Spartalizumab, Canakinumab)

    Recruiting
    • Carcinoma, Renal Cell
    • New York, New York
      Columbia University Medical Center
    May 6, 2022

    Anemia, MDS Trial in Germany (Canakinumab Injection)

    Recruiting
    • Anemia
    • Myelodysplastic Syndromes
    • Canakinumab Injection
    • Berlin, Germany
    • +5 more
    Nov 8, 2022

    Duchenne Muscular Dystrophy Trial in Washington (Canakinumab Injection [Ilaris])

    Recruiting
    • Duchenne Muscular Dystrophy
    • Canakinumab Injection [Ilaris]
    • Washington, District of Columbia
      Children's National Medical Center
    Mar 1, 2022

    NSCLC Trial in United States (Canakinumab, Durvalumab, Radiation therapy)

    Recruiting
    • Non-small Cell Lung Cancer
    • Canakinumab
    • +3 more
    • Basking Ridge, New Jersey
    • +6 more
    Aug 15, 2022

    Metastatic Pancreatic Ductal Adenocarcinoma Trial in Boston, New York (Canakinumab injection; spartalizumab, nab-paclitaxel,

    Active, not recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • Canakinumab injection; spartalizumab, nab-paclitaxel, gemcitabine
    • Boston, Massachusetts
    • +1 more
    Apr 5, 2022

    Adult Onset Still's Disease Trial in Japan (Canakinumab)

    Recruiting
    • Adult Onset Still's Disease
    • Canakinumab
    • Nagoya, Aichi, Japan
    • +15 more
    Jul 14, 2022

    Lung Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Houston (Canakinumab, Quality-of-Life

    Recruiting
    • Lung Carcinoma
    • +12 more
    • Canakinumab
    • Quality-of-Life Assessment
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 17, 2021

    NSCLC Trial in Worldwide (canakinumab, pembrolizumab)

    Completed
    • Non-small Cell Lung Cancer
    • La Jolla, California
    • +28 more
    Sep 27, 2022

    Coronavirus Infection, Diabetes, Type 2 Trial in Switzerland (Canakinumab, Placebo)

    Completed
    • Coronavirus Infection
    • Diabetes Mellitus, Type 2
    • Canakinumab
    • Placebo
    • Aarau, Switzerland
    • +8 more
    Sep 7, 2021

    Pulmonary Sarcoidosis Trial in Germany, Netherlands, United States (ACZ885, Placebo)

    Completed
    Has Results
    • Pulmonary Sarcoidosis
    • Birmingham, Alabama
    • +7 more
    Sep 30, 2021

    NOMID, CINCA Syndrome Trial run by the (Canakinumab)

    Terminated
    Has Results
    • NOMID
    • CINCA Syndrome
    • Canakinumab
    • Bethesda, Maryland
      National Institute of Arthritis and Musculoskeletal and Skin Dis
    Jun 9, 2021

    COVID-19, SARS-CoV 2 Trial in Weston, Cleveland (Canakinumab Injection 600mg, Canakinumab Injection 300mg, Placebos)

    Completed
    Has Results
    • COVID-19
    • SARS-CoV 2
    • Canakinumab Injection 600mg
    • +2 more
    • Weston, Florida
    • +1 more
    Apr 13, 2021

    Skin Inflammation, Allergic Contact Dermatitis Trial in Worcester (drug, other, device)

    Recruiting
    • Skin Inflammation
    • Allergic Contact Dermatitis
    • Squaric Acid Dibutyl Ester
    • +12 more
    • Worcester, Massachusetts
      University of Massachusetts Chan Medical School
    Sep 6, 2022

    Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma Trial in Worldwide (PDR001, ACZ885, CJM112)

    Completed
    • Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma
    • PDR001
    • +4 more
    • Baltimore, Maryland
    • +22 more
    Mar 15, 2022

    Sickle Cell Anemia Trial in Worldwide (ACZ885, Placebo)

    Completed
    Has Results
    • Sickle Cell Anemia
    • Atlanta, Georgia
    • +14 more
    Oct 7, 2021